Cash and Cash Equivalents, at Carrying Value of Evommune, Inc. from 30 Sep 2024 to 31 Dec 2025

Taxonomy & unit: us-gaap: USD
Description: Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.
Summary: Evommune, Inc. quarterly Cash and Cash Equivalents, at Carrying Value in USD history and change rate from 30 Sep 2024 to 31 Dec 2025.
Evommune, Inc. Cash and Cash Equivalents, at Carrying Value for the quarter ending 31 Dec 2025 was $44,063,000, a 171% increase year-over-year.
Source SEC data: View on sec.gov

Cash and Cash Equivalents, at Carrying Value, Quarterly (USD)

Cash and Cash Equivalents, at Carrying Value, YoY Quarterly Change (%)

Evommune, Inc. Quarterly Cash and Cash Equivalents, at Carrying Value (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q4 2025	$44,063,000	+$27,808,000	+171%	31 Dec 2025	10-K	05 Mar 2026	2025	FY
Q3 2025	$26,818,000	+$8,672,000	+48%	30 Sep 2025	10-Q	11 Dec 2025	2025	Q3
Q4 2024	$16,255,000			31 Dec 2024	10-K	05 Mar 2026	2025	FY
Q3 2024	$18,146,000			30 Sep 2024	10-Q	11 Dec 2025	2025	Q3

* An asterisk sign (*) next to the value indicates that the value is likely invalid.